How big is the leukapheresis market?

The global leukapheresis market size was estimated at USD 211.3 million in 2024 and is expected to reach USD 233.3 million in 2025.

What is the leukapheresis market growth?

The global leukapheresis market is expected to grow at a compound annual growth rate of 11.05% from 2025 to 2030 to reach USD 394.1 million by 2030.

Which segment accounted for the largest leukapheresis market share?

North America dominated the leukapheresis market with a share of 36.86% in 2024 and is expected to grow at the highest CAGR over the forecast period. This is attributable to growing technological advancements and the presence of key players operating in the market.

Who are the key players in the leukapheresis market?

Some key players in the leukapheresis market include Charles River Laboratories International, Inc.; Adacyte Therapeutics; AllCells, LLC; Asahi Kasei Medical; Haemonetics Corporation; Macopharma; Cerus Corporation; SB-Kawasumi Laboratories, Inc.;

What are the factors driving the leukapheresis market?

Key factors driving the leukapheresis market growth include the increasing prevalence of blood disorders and autoimmune diseases, technological advancements in leukapheresis procedures, and growing demand for personalized medicine.